Skip to main content

ctDNA Assays

The Agilent Resolution ctDx platform uses proprietary hybrid capture technology for next-generation sequencing (NGS) and bioinformatics to detect genomic alterations in cell-free DNA (cfDNA) from blood.

Refine By



Sort Alphabetically

Filter by
Filter Content Selection Tool

Need Help? Find products using our Selection Tool.

0 product selected.

Clear All